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Comparison of the outcomes of the TOT technique using a
hand-made TOT material and a commercial one
Ahmet Tunç ÖZDEMİR1, Serkan ALTINOVA1, Hacı İbrahim ÇİMEN1, Ege Can ŞEREFOĞLU1,
Hasbey Hakan KOYUNCU2, Mesut GÜRDAL3

Aim: The purpose of this study was to compare the effectiveness of handmade transobturator tape (TOT) devices
(tailored polypropylene mesh by the surgeon during the operation) with commercially available ones.
Materials and methods: We included 78 consecutive women with the complaint of pure stress urinary incontinence
recalcitrant to lifestyle modifications, pelvic floor muscle training, and medical treatment. The patients underwent TOT
procedures either with a commercially available product (I-Stop, CL Medical, Lyon, France) (group 1) or with a device
prepared during the operation with polypropylene mesh of 35 × 2 cm in size (Prolen®, Ethicon Inc., Somerville, New
Jersey, USA) (group 2). The patients were followed for at least 18 months and cure was defined as the absence of any
episodes of involuntary urine leakage during stressful activities and/or the stress cough test.
Results: Thirty-two (group 1) and 46 (group 2) patients underwent TOT surgery. Mean operation time was slightly
shorter in group 1 compared to group 2 (20.53 ± 4.88 vs. 22.93 ± 4.84, P = 0.035); however, mean duration of the
indwelling catheter was less than 1 day in both groups (P = 0.444). None of the patients had incontinence or urinary
retention postoperatively. The cure rates in groups 1 and 2 were not significantly different at the end of the 1st (87.5% vs.
87%, P = 0.944) and 2nd (78.1% vs. 80.4%, P = 0.804) postoperative years.
Conclusion: TOT procedures performed with polypropylene mesh and No. 1 silk line are as effective and safe as
commercially available TOT devices.
Key words: Midurethral sling, stress urinary incontinence, transobturator tape

Introduction
Stress urinary incontinence (SUI) is common among
middle-aged women and its prevalence rates increase
with age, reaching 45% at 60 years (1). Although
several treatment modalities have been previously
proposed, midurethral slings have radically changed
its surgical management and several procedures
for midurethral slings have been developed (1,2).
In a quest to find a minimally invasive sling that is
associated with even less morbidity than the tensionfree vaginal tape (TVT), transobturator tape (TOT)
surgery was introduced (3). Indeed, this approach

was found to be associated with lower complication
rates and shorter operating times. With objective
and subjective cure rates of up to 80% and 92%,
respectively, the TOT procedure became a mainstay
of surgical treatment for SUI (4–6). However, the
cost of the commercially available devices used for
the TOT procedure is expensive, which limits their
widespread use, especially in developing countries.
In this study, we compared the effectiveness of
handmade TOT devices (tailored polypropylene
mesh) with a commercially available, ready-to-use
TOT device.
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Material and methods
Study population: Between May 2006 and January
2011, 78 consecutive women with the complaint
of pure SUI that was recalcitrant to lifestyle
modifications, pelvic floor muscle training, and
medical treatment were included. All subjects gave
their written informed consent before entering the
study, which was conducted in accordance with the
Declaration of Helsinki. The local medical ethical
committee approved the study.
Characteristics such as body mass index (BMI),
menopausal status, the number of pads used per day,
and history of previous surgery of the patients were
recorded. Physical examination (including detailed
pelvic examination), urine analysis, and urodynamic
evaluation was systematically performed according
to the standards recommended by the International
Continence Society (7). None of the patients had
concomitant urge incontinence, pure intrinsic
sphincter deficiency, neurogenic bladder, residual
volume over 50 mL, pelvic organ prolapse, or previous
radical pelvic surgery.
Surgical procedure: The operation was performed
under either general or regional anesthesia as
described by Delorme (3). At the beginning, a 16F
Foley catheter was inserted into the bladder in
the lithotomy position after administration of a
prophylactic antibiotic (cefoxitin, 2 g intravenously).
The anterior vaginal wall was suspended with Allis
clamps and the mucosa was incised horizontally at
the midpoint between the Foley balloon and the
external urethral meatus. Helical needles designed
for the transobturator process were inserted through
skin incisions lateral to the labia major on both sides,
by tracing a horizontal line at the level of the urethral
meatus. Afterwards, these needles were tunneled
through the obturator foramens until their tips were
seen in the incision made on the anterior vaginal
wall.
After this stage, either the commercially available
product (I-Stop, CL Medical, Lyon, France) (group 1)
or the hand-made tape (group 2) was used. In group
2, a polypropylene mesh of 35 × 2 cm in size (Prolen®,
Ethicon Inc., Somerville, New Jersey, USA) was
attached to the helical needles with No. 1 silk sutures,
and it was pulled out through the transobturator
tunnel, similar to the original procedure with care not

to twist the mesh and with no tension as guaranteed
by interposing a pair of scissors between the mesh
and the urethra so as to leave a space (3) (Figure). The
excessive parts of the mesh were cut off at the level
of subcutaneous tissue followed by the closure of the
skin incision.
The urethral catheter was removed the following
morning. The patients were followed for at least for
18 months and cure was defined as the absence of
any episodes of involuntary urine leakage during
stressful activities and/or the stress cough test. The
patients were asked to return for follow-up visits at
postoperative months 1 and 3, and every 3 months
thereafter. Follow-up visits included a detailed
medical interview, clinical examination, urine
analysis, and postvoid residual determination.
Peroperative, early postoperative (hematoma,
dysuria, infection), and late postoperative (erosions,
perineal pain, de novo dyspareunia, de novo urge, or
urge incontinence) complications were recorded. The
cure of SUI was defined as no leakage of urine during
stressful activities and a stress cough test. Patients
who did not meet these criteria were considered to
have “failed” treatment (8).
Statistical analysis: Statistical analysis of the data
was performed by using Student’s t-test, the chisquare test, and Fisher’s exact test, for which SPSS
17.0 (SPSS Inc., Chicago, Illinois, USA) was used.
Statistical significance was set at P < 0.05. The cost

Figure. Picture of the tailored mesh and helical needles used
during TOT procedure.
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Table. The characteristics and outcomes of the patients.
Commercially available product (group
1, n = 32)

Tailored polypropylene mesh
(group 2, n = 46)

P-value

Age (years)

55.69 ± 6.89

52.63 ± 7.43

0.066

BMI (kg/m2)

25.13 ± 1.64

26.51 ± 3.17

0.014

Gravidity

3.50 ± 1.24

3.80 ± 1.43

0.335

Parity

3.19 ± 1.20

3.07 ± 1.16

0.654

16 (50%)

21 (45.7%)

0.819

5 (15.6%)

8 (17.4%)

1.000

95.93 ± 9.55

94.58 ± 9.92

0.550

Postmenopausal (%)
Cystocele (%)
VLPP (cmH2O)
Qmax (mL/s)
Voided volume (mL)

27.93 ± 5.72

27.63 ± 6.23

0.831

325.50 ± 65.68

327.23 ± 66.67

0.910

PVR (mL)

29.21 ± 4.64

28.95 ± 4.87

0.909

Operation time (min)

20.53 ± 4.88

22.93 ± 4.84

0.035

Catheterization time (h)

21.22 ± 3.22

20.65 ± 3.17

0.444

Follow-up (months)

20.16 ± 5.82

26.37 ± 3.92

0.532

Postoperative UTI (%)

2 (6.3%)

3 (6.5%)

1.000

De novo urgency

3 (9.4%)

3 (6.5%)

0.685

Urinary retention

3 (9.4%)

2 (4.3%)

0.396

Dysuria

1 (3.1%)

3 (6.5%)

0.640

BMI: body mass index; VLPP: Valsalva leak point pressure; Qmax: maximum flow rate; PVR: postvoid residual urine volume; UTI:
urinary tract infection.

of the hand-made and commercially available TOT
products was also compared.
Results
The characteristics of the patients in groups 1 and 2
are given in the Table. Patients in group 2 had slightly
higher BMI scores (P = 0.014), and the operation
time in group 1 was shorter than in group 2 (P =
0.035). Mean duration of the indwelling catheter was
less than 24 h in both groups (P = 0.444). None of the
patients had any episodes of incontinence or urinary
retention postoperatively.
The mean follow-up period was 20.16 ± 5.82 and
26.37 ± 3.92 months in groups 1 and 2 (P = 0.073). The
cure rates in groups 1 and 2 were similar at the end
of the 1st (87.5% vs. 87%, P = 0.944) and 2nd (78.1%
vs. 80.4%, P = 0.804) years postoperatively. There
were no peroperative complications (e.g., bladder
puncture, intestinal perforation, or nerve and vascular
damage) in either group. Minor complications such
1232

as urinary tract infections occurred in 2 (6.3%) and
3 (6.5%) patients in groups 1 and 2, respectively, and
de novo urgency occurred in 3 (9.4%) and 3 (6.5%),
all of which were successfully treated conservatively.
One patient (3.1%) in group 1 and 3 patients
(6.5%) in group 2 (P = 0.640) reported dysuria
and/or discomfort, all of whom responded well to
nonopioid analgesic treatment. Wound infection was
not observed in either group, whereas 2 patients in
each group suffered from vaginal erosion during the
follow-up period (P = 1.000). None of the patients
complained of pain 1 month after the surgery.
The commercial sling system costs approximately
€180.00 according to our hospital purchasing
commission. The hand-made sling used in this study
was fabricated from an original Prolen® Ethicon
mesh (30 × 30 cm), which costs €250.00. This mesh
was divided into 20 segments of 1.5 × 30 cm with 1
segment being used per surgery, corresponding to a
cost per patient of approximately €12.50 (€250.00/20
segments).
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Discussion
SUI is a prevalent condition that affects approximately
27% of women worldwide with far-reaching physical,
psychological, social, and economic implications
(9,10). In 1995, Ulmsten and Petros described a new
concept of midurethral support without tension for
urinary incontinence (1). However, concerns about
complications associated with this procedure (11,12)
elicited the development of different procedures,
such as TOT (8,11–14). These midurethral sling
methods are all based on the integral theory, which
proposes that the midurethra serves a significant role
in urinary continence and that the midurethral sling
provides continence by creating a functional kinking
of the midurethra during increased intraabdominal
pressure and the associated rotational descent of the
bladder neck and proximal urethra (15,16).
In 2001, Delorme (3) proposed the insertion of
vaginal tape through the obturator foramen, and de
Leval (17) reported a surgical success rate of 90.6%
with the same procedure. Similar rates were reported
by deTayrac (18), with a 1-year cure rate of 84%
with the TOT procedure. These successful results
popularized this procedure and ready-to-use TOT
devices have begun being manufactured by a number
of industrial companies.
In this study, we compared the complication
rates and long-term outcomes of TOT surgeries
performed with the use of either a commercially
available product or hand-made mesh. Although
peroperative TOT complications such as urethral or
bladder perforation and vascular damage have been
reported previously, none of these complications
occurred in our study (19,20). Urine retention and
voiding dysfunction rates were 9.4% and 4.3% in
groups 1 and 2, respectively, which are comparable
with the findings of previous studies (0% to 15.6%)
(16,21). Minor complications related to TOT are
urinary tract infections and de novo urgency
symptoms, which have a high impact on the quality
of life and have been reported to be as frequent as
0.8% to 47.2% (22,23). The incidences of these minor
complications were in accordance with previously
published series and were not statistically different
within groups. Finally, the cure rates at the end of the
1st (87.5% vs. 87%) and 2nd (78.1% vs. 80.4%) years
were similar in groups 1 and 2. These rates were not

different from the cure rates previously reported by
different authors (17,18).
In our study, 2 women in each group had vaginal
erosion. The mean time to erosion varied, which
confirms the importance of close follow-up when
symptoms like vaginal discharge, pain, or dyspareunia
occur postoperatively (24,25). We think that to avoid
erosion, not only the material used but also the
surgical technique is important. Urethral injuries are
believed to occur because of poor surgical technique,
local infection, or excessive tension placed on the
tape as these damage the integrity of the urethral
tissue or its blood supply; the most important step
to avoid erosion is to adjust the tape used against any
tension or any contact with the urethra (26).
To our knowledge, this is the first study that
compared the outcomes of TOT procedures
performed with hand-made polypropylene mesh
and commercially available products. However,
in a recent study, Chen et al. (27) compared the
efficacy of TVT and TOT procedures performed
with self-tailored monofilament mesh. Although the
authors did not find significant difference in success
rates (95% vs. 96% in the TVT and TOT groups,
respectively), they concluded that the TOT procedure
was faster, more economical, and associated with
fewer bladder complications. Similarly, our findings
suggest that TOT procedures performed with handmade polypropylene mesh are as safe and effective
as those performed with the commercially available
TOT devices. Effective and rational management of
health care expenditures by reducing costs without
compromising safety with the use of economical
alternative techniques for common health problems
such as SUI would be of great importance.
Since commercially available TOT products are
approximately 15 times more expensive than the cost
of a hand-made polypropylene mesh, tailoring the
TOT material would result in a reduction in the cost
of surgery done for this common medical problem.
TOT procedures performed with tailored
polypropylene mesh are as effective and safe as
those using commercially available TOT devices.
Significant reduction in the cost of utilized materials
can be achieved and this may be considered as an
alternative to commercially available products.
However, further studies are required to confirm our
findings.
1233
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